Table 1.

Results of ABMT With Unpurged Marrow in Adult AML in CR1

Institution No. of PatientsPretransplant Regimen Actuarial Incidence of (at months) Reference
LFS Relapse
London University College  76  Chemo combination  50 (60)  47  39 
Umea  30  BU-CY 2  40 (48)  —  40 
City of Hope  60  CY/VP16/+FTBI  49-150 and 61-151 44-150 and 33-151 41  
Bologna  51  BUCY 2-4 70.6 (60)  25.5  42  
Roma  191  BAVC BUCY2 37 (156)  47  43  
Barcelona  46  CY + TBI 48  48  44  
Madrid  30  BU-CY2  38 (60) 54  45  
Sutton  74  HDM/TBI  34  53  46 
EBMT  598  All regimens combined  42 (60)  52 47 
Institution No. of PatientsPretransplant Regimen Actuarial Incidence of (at months) Reference
LFS Relapse
London University College  76  Chemo combination  50 (60)  47  39 
Umea  30  BU-CY 2  40 (48)  —  40 
City of Hope  60  CY/VP16/+FTBI  49-150 and 61-151 44-150 and 33-151 41  
Bologna  51  BUCY 2-4 70.6 (60)  25.5  42  
Roma  191  BAVC BUCY2 37 (156)  47  43  
Barcelona  46  CY + TBI 48  48  44  
Madrid  30  BU-CY2  38 (60) 54  45  
Sutton  74  HDM/TBI  34  53  46 
EBMT  598  All regimens combined  42 (60)  52 47 

Abbreviation: LFS, leukemia-free survival.

F0-150

By intention to treat.

F0-151

Autografted patients only.

Close Modal

or Create an Account

Close Modal
Close Modal